3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
16
Thoracic
3
Lymphoid
3
Gastrointestinal
3
Breast
3
Gynecologic
2
Genitourinary
2
Endocrine
2
Dermatologic
2
CNS
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Conditions
Head and Neck Neoplasms
34
Squamous Cell Carcinoma of Head and Neck
32
Nasopharyngeal Carcinoma
22
Mouth Neoplasms
10
Oropharyngeal Neoplasms
8
Carcinoma, Squamous Cell
8
Laryngeal Neoplasms
7
Neoplasms
6
Melanoma
5
Lung Neoplasms
5
Colorectal Neoplasms
5
Pharyngeal Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Kidney Neoplasms
4
Breast Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Recurrence
2
Paranasal Sinus Neoplasms
2
Nasopharyngeal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Laryngeal Diseases
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Interventions
pembrolizumab
11
Nivolumab
6
Cetuximab
5
Gemcitabine
4
Filgrastim
4
Cisplatin
4
Carboplatin
4
tislelizumab
3
Radiosurgery
3
Ipilimumab
3
Injections
3
Fluorouracil
3
Docetaxel
3
Cyclophosphamide
3
Bortezomib
3
toripalimab
2
spartalizumab
2
poly ICLC
2
pazopanib
2
entrectinib
2
durvalumab
2
cemiplimab
2
belinostat
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Riluzole
2
Peripheral Blood Stem Cell Transplantation
2
Oncolytic Virotherapy
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Drug Therapy
×
Head & Neck
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled